|
|
|
|
| LEADER |
00000cam a2200000Mi 4500 |
| 001 |
EBOOKCENTRAL_ocn923265433 |
| 003 |
OCoLC |
| 005 |
20240329122006.0 |
| 006 |
m o d |
| 007 |
cr |n||||||||| |
| 008 |
151010s1900 dcu o 000 0 eng d |
| 040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d OCLCQ
|d MERUC
|d ZCU
|d ICG
|d OCLCO
|d OCLCQ
|d LVT
|d DKC
|d AU@
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCQ
|
| 020 |
|
|
|a 9780309598354
|
| 020 |
|
|
|a 0309598354
|
| 029 |
1 |
|
|a DEBBG
|b BV044107373
|
| 035 |
|
|
|a (OCoLC)923265433
|
| 050 |
|
4 |
|a RG137.6.M5
|
| 082 |
0 |
4 |
|a 618.8
|
| 049 |
|
|
|a UAMI
|
| 100 |
1 |
|
|a Staff, Institute of Medicine.
|
| 245 |
1 |
0 |
|a Clinical Applications of Mifepristone (RU486) and Other Antiprogestins :
|b Assessing the Science and Recommending a Research Agenda.
|
| 260 |
|
|
|a Washington :
|b National Academies Press,
|c 1900.
|
| 300 |
|
|
|a 1 online resource (304 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a ""Clinical Applications of Mifepristone (RU 486) and Other Antiprogestins""; ""Copyright""; ""Preface""; ""Contents""; ""Summary""; ""CROSS-CUTTING RECOMMENDATIONS""; ""USES OF ANTIPROGESTINS: THE REPRODUCTIVE CYCLE""; ""Contraception""; ""Post-Coital Contraception""; ""Menses Induction""; ""Pregnancy Termination During the First Trimester""; ""Pregnancy Termination During the Second Trimester""; ""Cervical Ripening""; ""Labor Induction in Late Pregnancy""; ""OTHER POTENTIAL THERAPEUTIC USES OF ANTIPROGESTINS""; ""Endometriosis""; ""Uterine Leiomyomas (Fibroids)""; ""Breast Cancer""
|
| 505 |
8 |
|
|a ""Meningioma""""ANTIGLUCOCORTICOID EFFECTS OF ANTIPROGESTINS""; ""1 Introduction""; ""BACKGROUND AND HISTORICAL PERSPECTIVES""; ""Finding an Antiprogestin""; ""THE IOM REPORT""; ""CROSS-CUTTING RECOMMENDATIONS""; ""REFERENCES""; ""2 Uses of Antiprogestins: The Reproductive Cycle (Part I)""; ""CONTRACEPTION""; ""POST-COITAL CONTRACEPTION""; ""MENSES INDUCTION""; ""REFERENCES""; ""3 Uses of Antiprogestins: The Reproductive Cycle (Part II)""; ""PREGNANCY TERMINATION DURING THE FIRST TRIMESTER""; ""Health Services Research""; ""PREGNANCY TERMINATION DURING THE SECOND TRIMESTER""
|
| 505 |
8 |
|
|a ""CERVICAL RIPENING""""LABOR INDUCTION IN LATE PREGNANCY""; ""Fetal Demise""; ""SUMMARY""; ""REFERENCES""; ""4 Other Therapeutic Uses of Antiprogestins""; ""ENDOMETRIOSIS""; ""Utility of Mifepristone (RU 486) for Treatment of Endometriosis""; ""Summary""; ""UTERINE LEIOMYOMAS (FIBROIDS)""; ""Utility of Mifepristone for Treatment of Uterine Leiomyomas""; ""BREAST CANCER""; ""Mechanism of Action""; ""Clinical Issues""; ""Adjuvant Therapy and Chemoprevention""; ""Resistance""; ""Dose Issues""; ""Conclusions""; ""MENINGIOMAS""; ""Conclusions""; ""REFERENCES""
|
| 505 |
8 |
|
|a ""5 Antiglucocorticoid Effects of Antiprogestins""""GLUCOCORTICOID FUNCTION""; ""THERAPEUTIC USE OF MIFEPRISTONE (RU 486) AS ANANTIGLUCOCORTICOID""; ""ADVERSE ANTIGLUCOCORTICOID EFFECTS OF ANTIPROGESTINS""; ""REFERENCES""; ""6 Animals as Models for Studying Antiprogestins""; ""REFERENCES""; ""APPENDIXES""; ""A Agenda for the IOM Workshop ''Antiprogestins: Assessing the Science, "" April 13�14, 1993""; ""B Background Papers and Presentations (In Order of Presentation at IOM Workshop)""; ""B1 1993: RU 486�A DECADE ON TODAY AND TOMORROW""; ""ANTIHORMONES: THE 20 YEARS BEFORE RU 486""
|
| 505 |
8 |
|
|a ""CHEMISTRY: NOVEL MOLECULES""""CELLULAR AND MOLECULAR MECHANISMS OF ACTION OF ANTIPROGESTINS: THE RECEPTOR AT THE CENTER""; ""Ligand Binding""; ""Receptor Transconformation""; ""Heat Shock Protein Binding""; ""Receptor Dimerization""; ""Binding to DNA""; ""Studies of Chromatin""; ""Gene Transcription""; ""PHYSIOPHARMACOLOGICAL REPRODUCTIVE EFFECTS""; ""REPRODUCTIVE MEDICINE (TABLE B1.4)""; ""Voluntary Early Pregnancy Interruption""; ""Pregnancy Interruption After Nine Weeks of Amenorrhea""; ""Initiation of Labor""; ""Contragestive and Contraceptive Methods Using RU 486""
|
| 500 |
|
|
|a ""Emergency Post-Coital Contraception (Contraceptive or Contragestive According to When it is Applied)""
|
| 590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
| 650 |
|
0 |
|a Mifepristone
|x Research.
|
| 650 |
|
0 |
|a Abortifacients
|x Research.
|
| 650 |
|
0 |
|a Progesterone
|x Antagonists
|x Research.
|
| 650 |
|
6 |
|a Mifépristone
|x Recherche.
|
| 650 |
|
6 |
|a Abortifs
|x Recherche.
|
| 650 |
|
6 |
|a Antiprogestérones
|x Recherche.
|
| 700 |
1 |
|
|a Donaldson, Molla S.
|
| 700 |
1 |
|
|a Dorflinger, Laneta.
|
| 776 |
0 |
8 |
|i Print version:
|a Staff, Institute of Medicine.
|t Clinical Applications of Mifepristone (RU486) and Other Antiprogestins : Assessing the Science and Recommending a Research Agenda.
|d Washington : National Academies Press, ©1900
|z 9780309049498
|
| 856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=3376668
|z Texto completo
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL3376668
|
| 994 |
|
|
|a 92
|b IZTAP
|
